Healthcare Market Research Reports
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
20 Dec 2022  |  North America  |  Frost Radar
Frost Radar™: Global Medical Imaging Managed Equipment Services Market, 2022
A Benchmarking System to Spark Companies to Action ‒ Innovation That Fuels New Deal Flow and Growth Pipelines
As the number of aging, technologically obsolete imaging systems at medical facilities heightens the need for replacement to new imaging equipment with advanced technology, hospitals and imaging centers (especially in developing economies) seek Managed Equipment Services models that provide a viable long-term equipment procurement strategy. Managed...
$4,950.00
Special Price $4,207.50 save 15 %
-
14 Dec 2022  |  North America  |  Technology Research
Bionic Devices: Technology Innovations and Growth Opportunities
Disruptive Bionic Device Technologies Mimicking Natural Functioning of the Eyes, Kidneys, and Limbs
Bionic devices are mechatronic or electronic platforms that can perform the physical and biological functions of body parts or organs that are lost or damaged because of chronic conditions or accidents. Patients that suffer complete vision loss because of retinal diseases; upper and lower limb amputations caused by accidents or chronic diseases; an...
$4,950.00
Special Price $4,207.50 save 15 %
-
16 Nov 2022  |  North America  |  Frost Radar
Frost Radar™: Cell and Gene Therapy Contract Development and Manufacturing Organizations, 2022
A Benchmarking System to Spark Companies to Action-Innovation that Fuels New Deal Flow and Growth Pipelines
As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...
$4,950.00
Special Price $4,207.50 save 15 %
-
23 Aug 2022  |  North America  |  Frost Radar
Frost Radar™: US Liquid Biopsy, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...
$4,950.00
Special Price $4,207.50 save 15 %
-
19 Aug 2022  |  North America  |  Frost Radar
Frost Radar™: Healthcare Data Analytics, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Healthcare organizations must be able to manage, analyze, and interpret data in order to identify strategic, tactical, and operational insights for decision making. This allows providers and payers to provide the best ways of delivering high-quality care. There has been a slow but steady change in the healthcare industry at the very core of its bus...
$4,950.00
Special Price $4,207.50 save 15 %
-
17 Aug 2022  |  North America  |  Frost Radar
Frost Radar™: Global Clinical Trial IT Solutions Market, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
COVID-19 has accelerated the need for a faster, more accessible clinical trial process. During the height of the pandemic, in-person follow-ups for ongoing trials were replaced with hand-held devices that essentially built an ecosystem for home health care support services that can be easily leveraged to avoid or reduce participant dropout rates. ...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Apr 2022  |  North America  |  Frost Radar
Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...
$4,950.00
Special Price $3,712.50 save 25 %
-
29 Mar 2022  |  North America  |  Frost Radar
Frost Radar™: Global Robotic-assisted Surgical Devices, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
As the healthcare industry continues adjusting to the increasing diagnosis of lifestyle-related diseases and demand for affordable care, effective surgical procedures assisted by robotic devices and a decline in treatment costs look promising. Next-generation surgical robotic technology platforms complement and extend surgeons’ ability to minimiz...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Mar 2022  |  North America  |  Frost Radar
Frost Radar™: North American Clinical Documentation Improvement Market, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Clinical documentation improvement (CDI), a vital mechanism in documenting care in the healthcare space, is a strategic necessity that goes beyond a component in the broader revenue cycle management (RCM) of claims processing. It focuses on improved patient outcomes, supports data quality that tells an accurate story of the patient’s care, facili...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 Dec 2019  |  North America  |  Technology Research
Advances and Emerging Technologies in Interventional Radiology
Virtual and Augmented Reality Redefining the Future of Interventional Radiology
Interventional radiology is a specialized field of radiology for interpreting images while performing minimally invasive surgery. As the minimally invasive procedures are less expensive, less painful, and low risk than traditional surgeries, interventional radiology is gaining a lot of importance. Interventional radiology advances are primarily dir...
$4,950.00
Special Price $3,712.50 save 25 %